Lifecycle risk intelligence

The signal was there for months. The recall came anyway.

Medical device issues rarely appear suddenly. They emerge as weak signals over time — and current systems detect them too late. RP360 exists to close that gap.

Fig. 1 — Exposure window, typical Class II recallInteractive — set your own timings
Recall issued

≈7.6 months

of patient exposure removed — 85% of the window between when the mechanism becomes detectable and when the recall is finally written.

Volume-based surveillance· what happens today

Recall issued 9 months after the first signal — patients are exposed for that whole span.

RP360· mechanism-based detection

Detected at 6 weeks — while the corrective action still changes the outcome.

With the recall issued 9 months after the first signal and RP360 detecting the mechanism at 6 weeks, about 7.6 months of patient exposure is removed — 85% of the window.

01 / What we build

One mission, three instruments.

Every part of RP360 serves the same goal — helping medical device teams move from reactive compliance to predicting risk earlier.

Predict

RP360 Platform

Enterprise risk intelligence for medical device manufacturers. Identify emerging risk earlier, prioritize what matters, and act with confidence.

  • Emerging signal detection across complaints, MAUDE, literature and field data
  • Risk scoring and prioritization
  • Trend analysis and decision support

Learn

RP360 Academy

Expert-led education across regulatory, quality, risk and post-market intelligence — free foundational courses, certifications, exam prep, and deep learning tracks.

  • Structured learning tracks
  • Exam-aligned simulator with rationale on every answer
  • Shareable digital certifications

Create

RP360 Studio In development

Turning dense technical and regulatory material into clear, consistent video — so knowledge reaches the people who need it, at the pace the work demands.

02 / The platform

From signal to action.

Enterprise risk intelligence for medical device manufacturers — collecting data, detecting patterns, scoring risk, and driving clear next steps.

Step 01

Signals

Collect data from internal & external sources.

Step 02

Patterns

AI/ML detects patterns and emerging signals.

Step 03

Insights

Risk scoring and prioritization.

Step 04

Action

Drives decisions and prevents harm.

03 / Why earlier

Most organizations react. Leaders predict.

Detecting signals early prevents harm, reduces cost, and protects your brand.

80%

of recalls show warning signs months earlier

7–12 mo

median time from first signal to recall

440M

device units affected by US recalls in 2024 — up 55% on 2023

1,059

US device recall events in 2024, a four-year high

2024 US recall figures: Sedgwick State of the Nation Recall Index, 2025 edition.

04 / The Academy

Master medical device safety & regulatory affairs.

The Academy is an expert-led learning platform for medical device professionals, spanning regulatory affairs, quality systems, risk & safety, and post-market intelligence.

Tracks

Regulatory Affairs · Quality Systems · Risk & Safety · Post Market Intelligence

Exam prep

Exam-aligned simulator with a rationale on every answer

Free foundational courses — no payment required to start.

Structured tracks

  • Regulatory Affairs — FDA · MDR · 510(k) · Global Submissions
  • Quality Systems — CAPA · Complaint Handling · ISO 13485 · Internal Audits
  • Risk & Safety — Risk Management · FMEA · Human Factors · Design Controls
  • Post Market Intelligence — Signal Detection · Trending & Analytics · PMS · MDR Reporting

05 / Studio

Video generation, built for regulated content.

Our third capability is in development. The goal is the same as everything else we build: get the right knowledge to the right people faster — this time by turning dense technical and regulatory material into clear, consistent video.

Still early. If it's relevant to your team,tell us what you'd want from it.

06 / Who it's for

Built for the teams accountable for safety.

Medical device manufacturers — particularly quality, regulatory, post-market surveillance and risk management teams — that need to detect risk earlier across a device portfolio and support decisions with evidence.

Regulatory AffairsQuality SystemsPost Market SurveillanceRisk ManagementCardiovascularOrthopedicsDiagnostic ImagingSurgical RoboticsIn-Vitro DiagnosticsCombination ProductsClass III ImplantsDigital Health

Request a demo

Start detecting risk earlier.

Don't wait for signals to become problems.

Talk to our team